Insider · CIK 0001879231

Buck Kristen K

Reports to the SEC for 1 company · BASKING RIDGE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001879231

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,982 sh	$1.97	−$5,874.54	98,830
2026-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,147 sh	$1.97	−$4,229.59	93,462
2026-01-09	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	EVP, R&D and CMO	AAward	+13K sh	—	—	13,000
2026-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−3,221 sh	$1.97	−$6,345.37	95,609
2026-01-09	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+25K sh	—	—	104,794
2026-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,982 sh	$1.97	−$5,874.54	101,812
2025-01-10	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−456 sh	$3.73	−$1,700.88	79,794
2025-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,651 sh	$3.80	−$10.1K	85,021
2025-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,863 sh	$3.80	−$10.9K	82,158
2025-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−1,908 sh	$3.80	−$7,250.4	80,250
2025-01-09	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	EVP, R&D and CMO	AAward	+13K sh	—	—	13,000
2025-01-09	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+25K sh	—	—	87,672
2024-10-01	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−6,363 sh	$2.93	−$18.6K	62,672
2024-10-01	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+15K sh	$2.93	+$44K	69,035
2024-01-10	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−512 sh	$3.00	−$1,536	54,035
2024-01-09	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+27K sh	—	—	59,915
2024-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−3,221 sh	$3.08	−$9,920.68	56,694
2024-01-09	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	EVP, R&D and CMO	AAward	+14K sh	—	—	14,000
2024-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,147 sh	$3.08	−$6,612.76	54,547
2023-09-01	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,908 sh	$2.18	−$6,339.44	32,915
2023-01-10	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−512 sh	$3.19	−$1,635.84	35,823
2023-01-09	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+18K sh	—	—	38,482
2023-01-09	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−2,147 sh	$3.00	−$6,441	36,335
2023-01-09	LSTALISATA THERAPEUTICS, INC. · Stock Options (Right to Buy)A Award	EVP, R&D and CMO	AAward	+9,000 sh	—	—	9,000
2022-09-01	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+58K sh	$0.50	+$29K	377,203
2022-09-01	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−44.8K sh	$0.50	−$22.4K	307,244
2022-09-01	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−25.2K sh	$0.50	−$12.6K	352,020
2022-01-10	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−7,694 sh	$0.92	−$7,055.398	319,203
2022-01-10	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	EVP, R&D and CMO	AAward	+32.5K sh	—	—	32,500
2022-01-10	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+64.5K sh	—	—	326,897
2021-09-01	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	EVP, R&D and CMO	AAward	+1.14M sh	—	—	1,137,915
2021-09-01	LSTALISATA THERAPEUTICS, INC.A Award	EVP, R&D and CMO	AAward	+313K sh	—	—	312,500
2021-09-01	LSTALISATA THERAPEUTICS, INC.F Tax Payment	EVP, R&D and CMO	FTax Payment	−50.1K sh	$1.28	−$64.1K	262,397

Recent filings

Accepted (ET)
Jan 134
Buck Kristen K0001879231-26-000003
SEC(opens sec.gov)
Jan 134
Buck Kristen K0001879231-25-000002
SEC(opens sec.gov)
Oct 24
Buck Kristen K0001879231-24-000004
SEC(opens sec.gov)
Jan 114
Buck Kristen K0001879231-24-000002
SEC(opens sec.gov)
Sep 54
Buck Kristen K0001879231-23-000005
SEC(opens sec.gov)

Companies

LISATA THERAPEUTICS, INC.EVP, R&D and CMOLSTA

Address

C/O LISATA THERAPEUTICS, INC. 110 ALLEN ROAD, 2ND FLOOR

BASKING RIDGE, NJ, 07920